Nanomix, Inc. Signs Exclusive Glucose Detection Licensing Agreement With MysticMD

EMERYVILLE, CA--(MARKET WIRE)--Nov 5, 2007 -- Nanomix Inc., a leading electronic detection company commercializing high-value diagnostic and monitoring applications, today announced an exclusive licensing agreement with MysticMD Inc., a provider of proprietary nano-coatings. Per this agreement, MysticMD will provide Nanomix with intellectual property related to the use of nano-ink for glucose test strip technology. This builds upon earlier work between the two organizations to optimize the technology and explore partnering opportunities.

MORE ON THIS TOPIC